Stockhead on MSN4h
In big news week Neurizon secures key orphan status for motor neurone drug in Europe
Twas the week before Christmas and the good news was flowing for clinical stage biotech Neurizon Therapeutics (ASX:NUZ), ...
Le Lézard19h
Neurizon Files IND Application to Support HEALEY ALS Platform Trial
Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001The IND is a comprehensive dossier of ...